comparemela.com
Home
Live Updates
Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights : comparemela.com
Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
Silence also announced positive topline 36-week data from ongoing phase 2 study of zerlasiran in patients with high lipoprotein
Company to host conference call and webcast today at 8 a.m. EDT / 12...
Related Keywords
United Kingdom ,
Hansoh Pharma ,
Rhonda Hellums ,
Craig Tooman ,
Astrazeneca ,
Exchange Commission ,
Nasdaq ,
Silence Therapeutics ,
Chief Financial Officer ,
Year End ,
Sales Agreement ,
Securities Litigation Reform Act ,
Admission Document ,
Annual Report ,
Markets ,
comparemela.com © 2020. All Rights Reserved.